• <tr id='mVo9KX'><strong id='mVo9KX'></strong><small id='mVo9KX'></small><button id='mVo9KX'></button><li id='mVo9KX'><noscript id='mVo9KX'><big id='mVo9KX'></big><dt id='mVo9KX'></dt></noscript></li></tr><ol id='mVo9KX'><option id='mVo9KX'><table id='mVo9KX'><blockquote id='mVo9KX'><tbody id='mVo9KX'></tbody></blockquote></table></option></ol><u id='mVo9KX'></u><kbd id='mVo9KX'><kbd id='mVo9KX'></kbd></kbd>

    <code id='mVo9KX'><strong id='mVo9KX'></strong></code>

    <fieldset id='mVo9KX'></fieldset>
          <span id='mVo9KX'></span>

              <ins id='mVo9KX'></ins>
              <acronym id='mVo9KX'><em id='mVo9KX'></em><td id='mVo9KX'><div id='mVo9KX'></div></td></acronym><address id='mVo9KX'><big id='mVo9KX'><big id='mVo9KX'></big><legend id='mVo9KX'></legend></big></address>

              <i id='mVo9KX'><div id='mVo9KX'><ins id='mVo9KX'></ins></div></i>
              <i id='mVo9KX'></i>
            1. <dl id='mVo9KX'></dl>
              1. <blockquote id='mVo9KX'><q id='mVo9KX'><noscript id='mVo9KX'></noscript><dt id='mVo9KX'></dt></q></blockquote><noframes id='mVo9KX'><i id='mVo9KX'></i>
                position: EnglishChannel > Visual?Stories > Article

                China publishes white paper on fight against COVID-19

                Source: XINHUA| 2020-06-07 19:32:16| Author: XINHUA

                China publishes white paper on fight against COVID-19

                Xinhua丨Updated: June 7, 2020

                A press conference is held by the State Council Information Office in Beijing, capital of China, June 7, 2020. China on Sunday issued a white paper on the country's battle against COVID-19. The white paper, titled "Fighting COVID-19: China in Action," was issued by the State Council Information Office. [Photo/Xinhua]

                The white paper, titled "Fighting COVID-19: China in Action," was issued by the State Council Information Office.

                The Chinese government released the white paper to keep a record of the country's efforts in its own fight against the virus, to share its experience with the rest of the world, and to clarify its ideas on the global battle, according to the white paper.

                The COVID-19 global pandemic is the most extensive to afflict humanity in a century, it said.

                Facing the "unknown, unexpected, and devastating disease," China launched a resolute battle to prevent and control its spread, the white paper said.

                Making people's lives and health its first priority, China adopted extensive, stringent, and thorough containment measures, and has for now succeeded in cutting all channels for the transmission of the virus, it added.

                Besides the foreword and afterword, the white paper consists of four parts: "China's Fight against the Epidemic: A Test of Fire," "Well-Coordinated Prevention, Control and Treatment," "Assembling a Powerful Force to Beat the Virus," and "Building a Global Community of Health for All."


                Top News

                • Facing the once-in-a-century global pandemic, it can be said that traditional Chinese medicine (TCM) has stood the test," said Tong Xiaolin, an academician with the Chinese Academy of Sciences and head of the treatment group of the National Administration of Traditional Chinese Medicine, at a conference on medicine and life health held this year in Nanjing.

                Haploid induction greatly speeds up maize breeding process

                The new haploid breeding technology has significantly sped up the process of maize breeding in China, said Dai Jingrui, an academician of the Chinese Academy of Engineering (CAE) and a professor at China Agricultural University (CAU).

                A Future to Expect: International S&T Community Expresses High Hope in Cooperation with Peers in China

                According to the latest news from Science and Technology Daily (April 14th), two COVID-19 inactivated vaccines were just approved for a phase I & II combined clinical trial by the National Medical Products Administration (NMPA) of China, making them the first batch in this category. The two vaccines were developed respectively by Wuhan Institute of Biological Products Co., Ltd of Sinopharm and Sinovac Research & Development Co., Ltd together with research institutes.

                Copyright ? Science and Technology Daily, All Rights Reserved

                mailto: yuhy@stdaily.com